Indeed, as seen previously, simultaneous administration of the selective SERT inhibitor sertraline and the selective DAT inhibitor vanoxerine resulted in a weak, albeit significant, reversal of Parkinsonism. This evidence concerns the gene SLC6A3 and Parkinsonism.